Implications for IABP Use in HF Shock With the New Allocation System

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Equity/Stock(s)/Options - REVAMPMedical</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences</li><li>Travel reimbursement - Ancora</li></ul>